{"status":"ok","message-type":"event-list","message":{"next-cursor":"0c1ab82e-f324-50fe-d42b-b3593b88e9e1","total-results":15,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-04-14T00:00:00Z","subj_id":"https:\/\/lens.org\/103-554-797-490-288","id":"08ced7ef-dc5f-529c-924a-257ae5ea929a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/103-554-797-490-288","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T01:16:46Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-06-24T00:00:00Z","subj_id":"https:\/\/lens.org\/154-344-932-415-024","id":"bfaf1a0e-4696-c564-4d2e-6cd15cb3883d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/154-344-932-415-024","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T14:23:02Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-23T00:00:00Z","subj_id":"https:\/\/lens.org\/158-334-047-812-146","id":"39aa0472-4132-676c-92cb-d848398e0913","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Biomarkers For Igf-1R Inhibitor Therapy","pid":"https:\/\/lens.org\/158-334-047-812-146","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T15:24:51Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-12-18T00:00:00Z","subj_id":"https:\/\/lens.org\/016-004-115-180-793","id":"3ad1ca63-3458-4c16-7535-7ceea3dcef8a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/016-004-115-180-793","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T15:51:26Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-01-29T00:00:00Z","subj_id":"https:\/\/lens.org\/160-351-967-895-85X","id":"39b580e2-f325-10de-ade9-0a246f8dac48","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/160-351-967-895-85X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T15:56:11Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-26T00:00:00Z","subj_id":"https:\/\/lens.org\/174-623-214-249-989","id":"18777189-b959-46c4-46d9-92604e277205","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/174-623-214-249-989","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T19:57:48Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-06-29T00:00:00Z","subj_id":"https:\/\/lens.org\/189-791-035-694-291","id":"7a70c2e7-7e96-a071-4ddc-d5e4083068d2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/189-791-035-694-291","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T00:15:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-21T00:00:00Z","subj_id":"https:\/\/lens.org\/190-504-544-306-366","id":"1a9e949b-b1d7-ba9b-898e-f7c7bf97adae","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/190-504-544-306-366","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T00:27:14Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-02-28T00:00:00Z","subj_id":"https:\/\/lens.org\/025-197-297-447-312","id":"60f82db6-87fc-865b-4536-90c80f7910df","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/025-197-297-447-312","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T04:30:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-26T00:00:00Z","subj_id":"https:\/\/lens.org\/037-068-488-591-231","id":"1ebaaa24-6a3d-0ef2-d196-9d05c3a57971","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/037-068-488-591-231","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T07:34:24Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-10-30T00:00:00Z","subj_id":"https:\/\/lens.org\/043-657-002-396-026","id":"a12f2edf-7ded-6e78-4c7f-556bee78cabf","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/043-657-002-396-026","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T09:16:59Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-09-14T00:00:00Z","subj_id":"https:\/\/lens.org\/053-654-455-001-444","id":"17171945-2ea2-887d-12c4-4a35c7b2894f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method Of Identifying Transmembrane Protein-Interacting Compounds","pid":"https:\/\/lens.org\/053-654-455-001-444","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T11:53:05Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-04-16T00:00:00Z","subj_id":"https:\/\/lens.org\/064-040-481-119-238","id":"28e345b6-9153-6c0e-2506-8e5b5d4540a4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/064-040-481-119-238","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T14:34:26Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-09-14T00:00:00Z","subj_id":"https:\/\/lens.org\/070-062-621-713-832","id":"98743c6e-325e-b4d9-ab48-3aa2c3bb1b06","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/070-062-621-713-832","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T16:07:19Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1210\/edrv.22.6.0452","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-09-14T00:00:00Z","subj_id":"https:\/\/lens.org\/095-351-979-700-292","id":"0c1ab82e-f324-50fe-d42b-b3593b88e9e1","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Anti-Igf-Ir Antibodies And Uses Thereof","pid":"https:\/\/lens.org\/095-351-979-700-292","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T23:17:30Z","relation_type_id":"cites"}]}}